Cancer Biomarker and Therapeutic Targeting

Led by Dr. Nehad Alajez

• Identification of the microRNA/lncRNA molecular signature associated with pathological complete response to neoadjuvant chemotherapy in Triple Negative (TN) breast cancer (BC).
• Circulating microRNAs and lncRNAs as novel biomarkers for early breast and colorectal cancer detection.
• Cell-based functional high-throughput small molecule library screens to identify novel therapeutic agents for breast and colorectal cancer.